Related references
Note: Only part of the references are listed.A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently
Wayne Macfadden et al.
BIPOLAR DISORDERS (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N. Yatham et al.
BIPOLAR DISORDERS (2009)
Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness
Emily M. Woltmann et al.
PSYCHIATRIC SERVICES (2007)
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia
GM Gharabawi et al.
SCHIZOPHRENIA RESEARCH (2005)
Risperidone in the treatment of acute mania - Double-blind, placebo-controlled study
S Khanna et al.
BRITISH JOURNAL OF PSYCHIATRY (2005)
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression
JR Calabrese et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder
CL Bowden et al.
JOURNAL OF CLINICAL PSYCHIATRY (2005)
Treatment of schizophrenia with long-acting injectable risperidone: A 12-month open-label trial of the first long-acting second-generation antipsychotic
WW Fleischhacker et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania
PE Keck et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial
PE Keck et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Clinical correlates of inpatient suicide
KA Busch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
M Tohen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization
J Scott et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Treatment non-adherence in affective disorders
R Lingam et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Using drug claims data to assess the relationship of medication adherence with hospitalization and costs
BL Svarstad et al.
PSYCHIATRIC SERVICES (2001)
Share Paper
